michyong2 Profile Banner
Michelle Yong Profile
Michelle Yong

@michyong2

Followers
995
Following
5K
Media
121
Statuses
681

ID physician, CMV & viral infections, Clinician researcher, @NCICancer @PeterMacCC @TheRMH @TheDohertyInst

Melbourne, Victoria
Joined September 2017
Don't wanna be here? Send us removal request.
@michyong2
Michelle Yong
8 months
Starting now @NCICancer Fungal Symposium with Prof Kontoyiannis speaking! A difficult case with proptosis with fungal elements. I know it’s Halloween in the US but having Dimitrios speak is a real treat ! 👻🎃@NCICancer @PergamIC @JulianLindsay_ @IchsGlobal @monicaslavin
Tweet media one
@NCICancer
NCIC
9 months
Final Countdown ⏰: Just 3 days to the Annual NCIC Symposium!. Join us in-person or online to hear world leading experts discuss 'Tackling #Fungal #Infections: Novel #Immune and #Diagnostic Approaches.'. Link to registration in the section below 👇
Tweet media one
1
0
12
@michyong2
Michelle Yong
9 months
RT @JoshuaHillMD: via @fredhutch With increasing infectious disease threats plus a growing population of people wit….
0
6
0
@michyong2
Michelle Yong
9 months
RT @IchsGlobal: #ICHSglobal now had country ambassadors to disseminate information about #immunocompromised host information throughout the….
0
3
0
@michyong2
Michelle Yong
9 months
RT @TakaMatsuo_ID: 【The heterogeneous syndrome of non-infectious causes of persistent fever in neutropenic patients with hematologic malign….
0
63
0
@michyong2
Michelle Yong
9 months
RT @RazonableMD: Secondary antiviral prophylaxis after treatment of CMV infection and disease: systematic review and metaanalysis. https://….
0
24
0
@michyong2
Michelle Yong
9 months
Thanks @GermHunterMD this is an important paper. Please read. EORTC/MSGERC criteria on host factors, repeat molecular testing , excluded these patients from meeting IA definitions - they have similar high mortality @NCICancer @monicaslavin.
0
3
9
@michyong2
Michelle Yong
9 months
Great to be here with @ChemalyRoy @banhocktan - we talk about challenges and controversies in CMV at APBMT. @IchsGlobal @NCICancer.
@ChemalyRoy
Dr Roy Chemaly
9 months
Tweet media one
0
2
17
@michyong2
Michelle Yong
9 months
RT @jschaenman: We are so fortunate to host #TxID and infx prevention expert Dr. Priya Garg joining us from Melbourne 🇦🇺 ⁦⁩- discussing ma….
0
3
0
@michyong2
Michelle Yong
9 months
RT @TakaMatsuo_ID: 【Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections】Curr Opin Infect Dis, Oc….
0
30
0
@michyong2
Michelle Yong
9 months
RT @victoriahall26: Poster presentations in session… presenting influenza-specific B & T cell analyses in pts w/ haematological malignancy….
0
5
0
@michyong2
Michelle Yong
10 months
RT @syctong: This is well worth a read, I've done so twice so far, if interested in Bayesian statistics for research and clinical trials. V….
0
20
0
@michyong2
Michelle Yong
10 months
RT @AbbyPDouglas: Really looking forward to co-chairing this important and stimulating session! Much to do in the AMS space in ICH, we will….
0
2
0
@michyong2
Michelle Yong
10 months
RT @MichaelGIsonMD: Please join ESGICH for our first session of our Webinar Series on September 24 at 12pm CET/8pm Melbourne/6am EST. This….
0
7
0
@michyong2
Michelle Yong
10 months
RT @DrNeha90356702: My view and quote on Chandipura virus in "The Lancet ".vector control, vaccine & surveillance @….
0
3
0
@michyong2
Michelle Yong
10 months
RT @NCICancer: Register now for our hybrid annual Symposium "Tackling Fungal infections" 10am Melbourne, Australia….
0
6
0
@michyong2
Michelle Yong
10 months
RT @TransplantJrnl: Quantiferon mediated CMV assay as a marker for cell mediated immunity to decide the duration of CMV prophylaxis in high….
0
32
0
@michyong2
Michelle Yong
11 months
RT @NCAS_Aus: Infectious diseases got the guernsey for the first @NEJM/@DGlaucomflecken TikTok. Very clever.
0
1
0
@michyong2
Michelle Yong
11 months
100% agree! So talented and experts in epidemiology, trials, data science, AI, implementation. Following your lead @jasonroberts_pk!! @NCICancer.
@jasonroberts_pk
Jason Roberts
11 months
@michyong2 @AbbyPDouglas @NCICancer @courtierano @NCAS_Aus @vzzhu1 @JulianLindsay_ @monicaslavin Well done @NCICancer - they are all excellent examples of highly successful clinician-research pharmacists. Future leaders who will reshape clinical care!.
0
1
3
@michyong2
Michelle Yong
11 months
Want to know how to join our research team @NCICancer?Want to ask an in depth question or evaluate how well we are managing infections in ICH? #TID Thursday hear about our amazing research fellows with pharm background. All welcome! @courtierano @NCAS_Aus @vzzhu1 @JulianLindsay_
Tweet media one
Tweet media two
1
2
11
@michyong2
Michelle Yong
1 year
Wonderful! Highly anticipated update on CMV definitions for trials as the field evolves. Highlights include updated refractory CMV and GI disease in SOT. A big collective effort by TAVI forum. @KottonNelson @ChemalyRoy @GenPapaMD @NCICancer.
@KottonNelson
Camille Nelson Kotton
1 year
Excited to have the newest version published - appreciate the teamwork with many including ⁦@RazonableMD⁩ ⁦@ChemalyRoy@NatoriYoichiro⁩ - Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients
0
0
10